All Bulletins

A New Era of “Breathing” Human Lung Organoids — Technology for Reproducing Dynamic Lung Mechanics Published in Biomaterials — Posted on: April 6, 2026 Author: HiLung Inc.

GHIT Fund and Thailand Science Research and Innovation to Strengthen Partnership through Co-funding Initiative Posted on: March 31, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)

Luxna Biotech and KH Neochem Launch Joint Research to Advance Next-Generation Deliverable Nucleic Acid Therapeutics Posted on: March 30, 2026 Author: Luxna Biotech Co., Ltd.

Luxna Biotech and Inabata Enter into a License Agreement for Manufacture and Sale of XenoModified Nucleic Acid Amidite “GuNA™” Posted on: March 13, 2026 Author: Luxna Biotech Co., Ltd.

Total Investment of Approx. USD 8.8 Million in Malaria, Tuberculosis, and NTD R&D Projects with Partners Including Mahidol University, Barcelona Institute for Global Health, and Eisai Posted on: February 4, 2026 Author: Global Health Innovative Technology Fund (GHIT Fund)

New Patent Issued in China (Patent No. ZL2021 8 0009880.7) Posted on: January 26, 2026 Author: C4U Corporation

New Patent Issued in Japan (Patent No. 7802303) Posted on: January 19, 2026 Author: Ｃ４Ｕ株式会社

C4U Announces the License Agreement with Euglena for CRISPR-Cas3 Technology Posted on: January 16, 2026 Author: C4U Corporation

New Patent Issued in Europe (European Patent No. 4303310) Posted on: December 25, 2025 Author: C4U Corporation

C4U Announces the Second License Agreement with RACTHERA for CRISPR-Cas3 Technology Posted on: December 25, 2025 Author: C4U Corporation

Announcement of the 19th JIHS Global Infectious Diseases Forum Posted on: December 11, 2025 Author: Japan Institute of Health Security (JIHS)

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others Posted on: December 8, 2025 Author: Global Health Innovative Technology Fund (GHIT Fund)